ASX Announcement | 26 October 2026 AdAlta Limited (ASX:1AD) QUARTERLY ACTIVITIES REPORT – SEPTEMBER QUARTER 2026 (Q1 FY27) EW-001 on the threshold of its first US FDA advice and first Australian manufacturing runs, as validation of AdAlta’s “East to West” strategy builds Investment...